These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34241636)

  • 1. Protein Phosphatase 2A (PP2A) mutations in brain function, development, and neurologic disease.
    Verbinnen I; Vaneynde P; Reynhout S; Lenaerts L; Derua R; Houge G; Janssens V
    Biochem Soc Trans; 2021 Aug; 49(4):1567-1588. PubMed ID: 34241636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
    Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
    Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPP2R5D-Related Intellectual Disability and Neurodevelopmental Delay: A Review of the Current Understanding of the Genetics and Biochemical Basis of the Disorder.
    Biswas D; Cary W; Nolta JA
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32074998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein phosphatase 2A - structure, function and role in neurodevelopmental disorders.
    Sandal P; Jong CJ; Merrill RA; Song J; Strack S
    J Cell Sci; 2021 Jul; 134(13):. PubMed ID: 34228795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The broad phenotypic spectrum of PPP2R1A-related neurodevelopmental disorders correlates with the degree of biochemical dysfunction.
    Lenaerts L; Reynhout S; Verbinnen I; Laumonnier F; Toutain A; Bonnet-Brilhault F; Hoorne Y; Joss S; Chassevent AK; Smith-Hicks C; Loeys B; Joset P; Steindl K; Rauch A; Mehta SG; Chung WK; Devriendt K; Holder SE; Jewett T; Baldwin LM; Wilson WG; Towner S; Srivastava S; Johnson HF; Daumer-Haas C; Baethmann M; Ruiz A; Gabau E; Jain V; Varghese V; Al-Beshri A; Fulton S; Wechsberg O; Orenstein N; Prescott K; Childs AM; Faivre L; Moutton S; Sullivan JA; Shashi V; Koudijs SM; Heijligers M; Kivuva E; McTague A; Male A; van Ierland Y; Plecko B; Maystadt I; Hamid R; Hannig VL; Houge G; Janssens V
    Genet Med; 2021 Feb; 23(2):352-362. PubMed ID: 33106617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability.
    Fevga C; Tesson C; Carreras Mascaro A; Courtin T; van Coller R; Sakka S; Ferraro F; Farhat N; Bardien S; Damak M; Carr J; Ferrien M; Boumeester V; Hundscheid J; Grillenzoni N; Kessissoglou IA; Kuipers DJS; Quadri M; ; ; Corvol JC; Mhiri C; Hassan BA; Breedveld GJ; Lesage S; Mandemakers W; Brice A; Bonifati V
    Brain; 2023 Apr; 146(4):1496-1510. PubMed ID: 36073231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants for PP2A substrate specificity: charged residues mediate dephosphorylation of tyrosine hydroxylase by the PP2A/B' regulatory subunit.
    Saraf A; Oberg EA; Strack S
    Biochemistry; 2010 Feb; 49(5):986-95. PubMed ID: 20017541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth.
    Loveday C; Tatton-Brown K; Clarke M; Westwood I; Renwick A; Ramsay E; Nemeth A; Campbell J; Joss S; Gardner M; Zachariou A; Elliott A; Ruark E; van Montfort R; ; Rahman N
    Hum Mol Genet; 2015 Sep; 24(17):4775-9. PubMed ID: 25972378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, neuroimaging and molecular characteristics of
    Oyama N; Vaneynde P; Reynhout S; Pao EM; Timms A; Fan X; Foss K; Derua R; Janssens V; Chung W; Mirzaa GM
    J Med Genet; 2023 May; 60(5):511-522. PubMed ID: 36216457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Targeting of PP2A enzymes by viral proteins and cancer signalling].
    Godet AN; Guergnon J; Galioot A; Falanga PB; Colle JH; Cayla X; Garcia A
    Med Sci (Paris); 2011 Dec; 27(12):1106-11. PubMed ID: 22192750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism.
    Shang L; Henderson LB; Cho MT; Petrey DS; Fong CT; Haude KM; Shur N; Lundberg J; Hauser N; Carmichael J; Innis J; Schuette J; Wu YW; Asaikar S; Pearson M; Folk L; Retterer K; Monaghan KG; Chung WK
    Neurogenetics; 2016 Jan; 17(1):43-9. PubMed ID: 26576547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation on the PPP2R5D B regulatory subunit modulates the biochemical properties of protein phosphatase 2A.
    Yu UY; Ahn JH
    BMB Rep; 2010 Apr; 43(4):263-7. PubMed ID: 20423611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologic functions of PP2A: Lessons from genetically modified mice.
    Reynhout S; Janssens V
    Biochim Biophys Acta Mol Cell Res; 2019 Jan; 1866(1):31-50. PubMed ID: 30030003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth.
    Papke CM; Smolen KA; Swingle MR; Cressey L; Heng RA; Toporsian M; Deng L; Hagen J; Shen Y; Chung WK; Kettenbach AN; Honkanen RE
    J Biol Chem; 2021; 296():100313. PubMed ID: 33482199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability.
    Houge G; Haesen D; Vissers LE; Mehta S; Parker MJ; Wright M; Vogt J; McKee S; Tolmie JL; Cordeiro N; Kleefstra T; Willemsen MH; Reijnders MR; Berland S; Hayman E; Lahat E; Brilstra EH; van Gassen KL; Zonneveld-Huijssoon E; de Bie CI; Hoischen A; Eichler EE; Holdhus R; Steen VM; Døskeland SO; Hurles ME; FitzPatrick DR; Janssens V
    J Clin Invest; 2015 Aug; 125(8):3051-62. PubMed ID: 26168268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Ppp2Ca and Ppp2Cb conditional null alleles in mouse.
    Gu P; Qi X; Zhou Y; Wang Y; Gao X
    Genesis; 2012 May; 50(5):429-36. PubMed ID: 21998041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPP2R1A neurodevelopmental disorder is associated with congenital heart defects.
    Baker EK; Solivio B; Pode-Shakked B; Cross LA; Sullivan B; Raas-Rothschild A; Chorin O; Barel O; Bar-Yosef O; Husami A; Hopkin RJ; Prada CE; Stottmann RW; Weaver KN
    Am J Med Genet A; 2022 Nov; 188(11):3262-3277. PubMed ID: 36209351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biogenesis of active protein phosphatase 2A holoenzymes: a tightly regulated process creating phosphatase specificity.
    Sents W; Ivanova E; Lambrecht C; Haesen D; Janssens V
    FEBS J; 2013 Jan; 280(2):644-61. PubMed ID: 22443683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer.
    Seshacharyulu P; Pandey P; Datta K; Batra SK
    Cancer Lett; 2013 Jul; 335(1):9-18. PubMed ID: 23454242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein phosphatase 2A regulatory subunit B56γ mediates suppression of T cell receptor (TCR)-induced nuclear factor-κB (NF-κB) activity.
    Breuer R; Becker MS; Brechmann M; Mock T; Arnold R; Krammer PH
    J Biol Chem; 2014 May; 289(21):14996-5004. PubMed ID: 24719332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.